Current Events

General Motors redesigned even more ignition switches on more models without changing the part number, according to a letter the automaker sent this week to government regulators.

The gist of this latest disclosure is that an undetermined number of the defective ignition switches likely remained in circulation among dealers who may have installed them in cars that didn’t originally have the problem.

Click here to read more.

Only three months ago, Mary T. Barra arrived for the first time on Capitol Hill to apologize — publicly, profusely and personally — for General Motors’ long failure to recall millions of small cars.

On Thursday, Ms. Barra returned to Washington again, and this time, she drew the line.

Click here to read more.

The car crash that killed Gene Erickson caught the attention of federal regulators. Why did the Saturn Ion he was traveling in, along a rural Texas road, suddenly swerve into a tree? Why did the air bags fail? General Motors told federal authorities that it could not provide answers.

But only a month earlier, a G.M. engineer had concluded in an internal evaluation that the Ion had most likely lost power, disabling its air bags, according to a subsequent internal investigation commissioned by G.M.

Click here to read more.

But another major component of the settlement has little to do with troubled mortgages. As part of the deal, Citigroup has also agreed to provide $180 million in financing to build affordable rental housing.

Click here to read more.

The two lawsuits filed Monday make Illinois the first state to target firms offering to help consumers repay their student loan debts in exchange for as much as $1,200 upfront. Others are expected as the mortgage crisis subsides, and regulators turn their attention to other financial scams, including outfits trying to help people repay more than $1 trillion in outstanding student loan debt.

Click here to read more.

Citigroup Inc. (C) and U.S. authorities will announce a $7 billion agreement as soon as today to end probes of the bank’s sales of mortgage-backed bonds, according to a person with direct knowledge of the matter.

The deal, signed over the weekend, requires the firm to pay $4 billion to the Justice Department, about $300 million to state attorneys general and about $200 million to the Federal Deposit Insurance Corp., and to provide $2.5 billion in relief for consumers, the person said, asking not to be named because the talks are private. The settlement includes a statement of facts, outlining the allegations, the person said.

Click here to read more.

A federal judge gave preliminary approval Monday to a revised settlement in concussion suits filed by former player against the NFL. That clears the way for ensuing legal steps that will, pending final approval, provide hundreds of millions of dollars in payments over the next 65 years to ex-players suffering from brain impairments.

U.S. District Judge Anita Brody issued her decision in Philadelphia, where more than 240 suits filed by more than 4,500 ex-players have been consolidated in a single class-action case.

Click here to read more.

MUMBAI, July 3 (Reuters) - India's Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.

The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in the western Indian state of Gujarat, the FDA said in a post on its website.

Click here to read more.

Johnson & Johnson (JNJ) will pay Oregon $4 million to resolve deceptive marketing claims over recalled metal-on-metal hip implants in its first accord with any governmental unit involving the devices.

While the sum is dwarfed by J&J’s earlier settlement of patient lawsuits linked to the ASR hip, the agreement may lead the way for additional accords as federal and multi-state probes continue into the company’s sales of the device.

Click here to read more.

The Food and Drug Administration is beefing up its oversight of pharmacies that create custom drugs in response to a 2012 meningitis outbreak linked to tainted medicines that left 64 people dead.

The FDA released regulations Tuesday for compounding pharmacies, which work with physicians to create specific drugs for individual patients, rather than mass producing pharmaceuticals for the public.

Click here to read more.

DETROIT — The deeper General Motors digs into its vast portfolio of vehicles, the more safety problems it finds.

The announcement on Monday that G.M. would recall another 8.4 million cars and trucks for a range of defects appears to be a direct result of the company’s new found vigilance to rooting out safety issues.

Click here to read more.